Projected Benefits For TerrAscend Overestimated, Says Cantor & Downgrades Cannabis Stock To 'Neutral'

Projected Benefits For TerrAscend Overestimated, Says Cantor & Downgrades Cannabis Stock To 'Neutral'

TerrAscend Corp. TRSSF reported its financial results on Thursday for the second quarter ending June 30, with net sales of $65 million, compared to $50 million in the previous quarter.

Gross Profit Margin was 35.5% as compared to 30.4% in Q1 2022.

Adjusted EBITDA was $5.8 million as compared to $3.3 million in Q1 2022.

TerrAscend shares are down 20% over the past 90 days compared to an 11% drop for the AdvisorShares Trust AdvisorShares Pure US Cannabis ETF MSOS, and a 7% gain for SPDR S&P 500 SPY.

The Analyst

Cantor Fitzgerald’s analyst Pablo Zuanic downgraded their rating on TerrAscend stock to ‘Neutral’ from ‘Overweight’ and lowered their price target to $2.85 from $6.45. 

The Thesis

Zuanic downgraded TerrAscend rating to address lower estimates and sectoral derating.

“We are downgrading TerrAscend on valuation (30% and 50% premium on our CY23 sales and EBITDA estimates to the MSO average),” the analyst said.

The company’s second-quarter sales came out 15% below the FactSet consensus, and Zuanic further believes that TerrAscend offered rich estimates – “there is no guidance, but we are 25% below second half of 2022 sales consensus and 50% on EBITDA.”

TerrAscend might benefit from far-reaching operations across New Jersey and general retail/wholesale growth in the state, as well as Gage expansion in Michigan. It has “recreational optionality in Pennsylvania and Maryland (although so do several other multi-state operators.” Zuanic said, adding that these benefits may be overestimated by consensus.

“We think there are more attractive options in the multi-state operators group to benefit from a likely year-end rally in the space,” Zuanic wrote.

Price Action 

TerrAscend shares were trading 4.80% at $2.4 per share at the time of writing Friday morning. 

Photo: Courtesy of Mikhail Nilov by Pexels

Posted In: Cantor FitzgeraldPablo ZuanicAnalyst ColorCannabisNewsPenny StocksSmall CapMarketsAnalyst Ratings


Meet the biggest cannabis industry players and make deals that will push the industry forward.

Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.

Join us September 13-14, 2022 at The Palmer House in Chicago, IL.